Pain Management in Special Populations
Pain management in special populations is the part of pain medicine concerned with groups for whom the assessment, mechanisms, or pharmacology of pain differ in important ways from the general adult patient. It groups together children, older adults, people living with substance use disorder, and pregnant patients, because each of these populations changes how pain is measured, how analgesics behave in the body, and which trade-offs guide care.
Definition
Pain management in special populations refers to the assessment and treatment of pain in patient groups whose age, physiology, comorbidity, or psychosocial circumstances make standard adult approaches to measurement and analgesia incomplete or unsafe without modification.
Scope
This area is an orienting overview that links its topic nodes rather than a self-contained clinical text. It covers why standard pain assessment tools and dosing assumptions, largely derived from healthy adults, require adaptation; how developmental, physiological, and social factors reshape the risk-benefit balance; and how guideline bodies frame care for each group. It does not provide dosing, prescriptions, or individualized treatment plans.
Sub-topics
Core questions
- Why do pain assessment tools validated in adults need adaptation for children, cognitively impaired older adults, and other groups?
- How do developmental and age-related changes in physiology alter how analgesics are handled by the body?
- How is the balance between adequate analgesia and harm reshaped by substance use disorder or by pregnancy?
- How do guideline bodies and the framing of pain relief as a quality-of-care concern apply across vulnerable groups?
Key concepts
- Population-specific pain assessment
- Developmental and age-related pharmacokinetics
- Risk-benefit balance under comorbidity
- Undertreatment of pain in vulnerable groups
- Maternal-fetal and developmental safety considerations
- Pain relief as a dimension of care quality
Mechanisms
The common thread across these populations is that two general assumptions of adult pain medicine break down. First, self-report tools and numeric rating scales presume a patient who can reliably communicate; young children, some older adults with cognitive impairment, and others require observational or adapted instruments instead. Second, dosing assumptions presume typical adult drug handling; immature or aged organ function, pregnancy-related physiological change, and altered tolerance in substance use disorder all shift how analgesics are absorbed, distributed, and cleared, and how the same exposure translates into effect and risk. Because of these shifts, the framing of pain relief as a basic dimension of good care has been used to argue against the systematic undertreatment that these groups have historically experienced.
Clinical relevance
This area orients readers to the groups in which pain is most often under-recognized or mis-measured and in which analgesic decisions carry distinctive trade-offs. It is reference and educational material describing how clinicians and guideline bodies think about these populations; it is not a source of dosing or individualized treatment advice.
Epidemiology
Children, older adults, pregnant patients, and people with substance use disorder together account for a large share of clinical encounters in which pain is present, and each group has been repeatedly documented to receive less adequate analgesia than comparable general adults. Guideline statements for older persons (American Geriatrics Society, 2009) and the reframing of pain relief as a quality concern (Brennan, Carr & Cousins, 2007) emerged partly in response to this pattern of undertreatment.
History
Interest in tailoring pain medicine to specific populations grew alongside recognition in the late twentieth century that pain was systematically undertreated in those least able to advocate for themselves, including infants once thought not to feel pain and older adults whose reports were discounted. Pediatric and geriatric pain emerged as distinct concerns, the human-rights framing of pain relief consolidated the ethical argument (Brennan, Carr & Cousins, 2007), and the ICD-11 chronic pain classification (Treede et al., 2015) gave a shared vocabulary that spans populations.
Key figures
- Charles Berde
- Frank Brennan
- Daniel Carr
- Rolf-Detlef Treede
Related topics
Seminal works
- brennan-2007
- berde-2002
- ags-2009
- treede-2015
Frequently asked questions
- What makes a population 'special' for pain management?
- A population is treated as special when its age, physiology, comorbidity, or circumstances mean that pain assessment tools and analgesic assumptions developed for general adults do not transfer directly and must be adapted to measure pain accurately and weigh benefit against harm appropriately.
- Does this area give treatment recommendations?
- No. It is an orienting reference that explains why these groups differ and links to detailed topic entries. It does not provide dosing, prescriptions, or individualized clinical advice.